These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3261191)

  • 21. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and clinical application of HLA-B27 antisera].
    Liu DL
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):144-6. PubMed ID: 3111660
    [No Abstract]   [Full Text] [Related]  

  • 23. Guilt by association: HLA-B27 and ankylosing spondylitis.
    Beukelman CJ; Van Leeuwen A
    Immunol Today; 1990 Aug; 11(8):270. PubMed ID: 2206268
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of ankylosing spondylitis: the state of the art.
    Calin A
    Br J Rheumatol; 1988; 27 Suppl 2():106-9. PubMed ID: 3042068
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.
    Cauli A; Dessole G; Fiorillo MT; Vacca A; Mameli A; Bitti P; Passiu G; Sorrentino R; Mathieu A
    Rheumatology (Oxford); 2002 Dec; 41(12):1375-9. PubMed ID: 12468816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blind confirmation of Geczy factor in ankylosing spondylitis.
    van Rood JJ; van Leeuwen A; Ivanyi P; Cats A; Breur-Vriesendorp BS; Dekker-Saeys AJ; Kijlstra A; van Kregten E
    Lancet; 1985 Oct; 2(8461):943-4. PubMed ID: 2865436
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls.
    Calin A; Marder A; Becks E; Burns T
    Arthritis Rheum; 1983 Dec; 26(12):1460-4. PubMed ID: 6606431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-B27, ankylosing spondylitis and polymorph motility.
    Pease CT; Currey HL
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):172-6. PubMed ID: 6606471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy.
    Beukelman CJ; Quarles van Ufford HC; van Bree FP; Aerts PC; Nieuwenhoff C; Reerink G; van Leeuwen A; van Dijk H
    Scand J Rheumatol Suppl; 1990; 87():74-9; discussion 79-80. PubMed ID: 2259890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27.
    Wakefield D; Easter J; Robinson P; Graham D; Penny R
    Clin Exp Immunol; 1986 Jan; 63(1):49-57. PubMed ID: 3485486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.
    Geczy AF; McGuigan LE; Sullivan JS; Edmonds JP
    J Exp Med; 1986 Sep; 164(3):932-7. PubMed ID: 3528379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional gel analysis demonstrates no structural alteration of HLA-B27 polypeptides between patients with ankylosing spondylitis and healthy individuals.
    Trapani JA; Walker ID; McKenzie IF
    Ann Rheum Dis; 1984 Apr; 43(2):177-80. PubMed ID: 6608922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ankylosing spondylitis, HLA-B27, and klebsiella.
    Geczy AF
    Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae.
    Archer JR
    Ann Rheum Dis; 1981 Aug; 40(4):400-3. PubMed ID: 7020615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
    Yoshikawa M; Nakamura S; Ohno S
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunogenetic study of the HLA system in families of patients with ankylosing spondylitis].
    Grubić Z; Kerhin-Brkljacić V; Cecuk-Jelicić E; Kastelan A
    Reumatizam; 2000; 47(1):13-9. PubMed ID: 11552604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterobacterial involvement in the pathogenesis of secondary ankylosing spondylitis.
    van Bohemen CG; Weterings E; Goei The HS; Grumet FC; Zanen HC
    Br J Rheumatol; 1988; 27 Suppl 2():61-7. PubMed ID: 2456814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.